Literature DB >> 3182914

Transient blindness and seizure associated with cisplatin therapy.

M T Cattaneo1, V Filipazzi, E Piazza, E Damiani, G Mancarella.   

Abstract

A 38-year-old woman with adenocarcinoma of unknown origin was treated with cisplatin and etoposide. After the 4th course of chemotherapy she complained of blindness and had a seizure with spontaneous recovery in 4 days. The relationship between these events and the known neurotoxicity of other heavy metals indicate cisplatin as a possible etiologic factor.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3182914     DOI： 10.1007/bf00391507

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN： 0171-5216            Impact factor:   4.553


  13 in total

1.  Ophthalmic pathological findings in a case of thallium poisoning.

Authors:  W A Manschot
Journal:  Ophthalmologica       Date:  1969       Impact factor: 3.250

2.  Etoposide and cis-platinum in non-small-cell bronchogenic carcinoma.

Authors:  J Klastersky; E Longeval; C Nicaise; D Weerts
Journal:  Cancer Treat Rev       Date:  1982-06       Impact factor: 12.111

3.  Synthesis and distribution of a radiolabeled antitumor agent: cis-diamminedichloroplatinum. II.

Authors:  R C Lange; R P Spencer; H C Harder
Journal:  J Nucl Med       Date:  1972-05       Impact factor: 10.057

4.  Delayed visual evoked potentials with bilateral disease of the posterior visual pathway.

Authors:  B Ashworth; A F Maloney; H R Townsend
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-05       Impact factor: 10.154

5.  Retinal toxicity after high-dose cisplatin therapy.

Authors:  G Wilding; R Caruso; T S Lawrence; Y Ostchega; E J Ballintine; R C Young; R F Ozols
Journal:  J Clin Oncol       Date:  1985-12       Impact factor: 44.544

6.  Central nervous system toxicity and cerebrospinal fluid pharmacokinetics of intraventricularly administered bleomycin in beagles.

Authors:  V A Levin; D Byrd; B I Sikic; B B Etiz; J Campbell; J K Borcich; R L Davis
Journal:  Cancer Res       Date:  1985-08       Impact factor: 12.701

7.  Neurotoxic effects of cisplatin therapy.

Authors:  T J Walsh; A W Clark; I M Parhad; W R Green
Journal:  Arch Neurol       Date:  1982-11

8.  Ophthalmologic toxicity after cis-dichlorodiammineplatinum(II) therapy.

Authors:  S Ostrow; D Hahn; P H Wiernik; R D Richards
Journal:  Cancer Treat Rep       Date:  1978-10

9.  Cerebral blindness in association with cis-platinum chemotherapy for advanced carcinoma of the fallopian tube.

Authors:  S B Diamond; S H Rudolph; S S Lubicz; G Deppe; C J Cohen
Journal:  Obstet Gynecol       Date:  1982-06       Impact factor: 7.661

10.  Seizures and transient cortical blindness associated with cis-platinum (II) diamminedichloride (PDD) therapy in a thirty-year-old man.

Authors:  I J Berman; M P Mann
Journal:  Cancer       Date:  1980-02-15       Impact factor: 6.860
View more
  3 in total

1.  Convulsions and transient cortical blindness after cisplatin.

Authors:  P A Philip; J Carmichael; A L Harris
Journal:  BMJ       Date:  1991-02-16

2.  Neurotoxicity caused by the treatment with platinum analogues.

Authors:  Sousana Amptoulach; Nicolas Tsavaris
Journal:  Chemother Res Pract       Date:  2011-06-27

3.  Effects of intensity-modulated radiotherapy and chemoradiotherapy on attention in patients with nasopharyngeal cancer.

Authors:  Qing Wei; Ling Li; Xiao-Dong Zhu; Ling Qin; Yan-Lin Mo; Zheng-You Liang; Jia-Li Deng; Su-Ping Tao
Journal:  Oncotarget       Date:  2017-07-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.